To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Ariadne Licenses PathwayStudio® to UCB
Ariadne Genomics, Inc. has announced that UCB has licensed its PathwayStudio® software to support early stages of the drug discovery process - target identification and biomarker research.
PathwayStudio comes with ResNet™ database of 500,000+ functional relationships and MedScan™ modules for automatic extraction of information from scientific literature.
The software is designed to enable life science researchers to interpret their own discoveries in the context of biological pathways and gene regulation networks; it makes it easy to identify relationships among proteins, small molecules, cell processes and treatments, reconstruct pathways from microarray and proteomics data, identify biomarkers, and model drug responses.
"PathwayStudio being a client-server application offers pharmaceutical research groups easy and flexible team-wide access to the database, as well as the power of whole PubMed data at their fingertips," commented Ilya Mazo, President of Ariadne Genomics.
